CHARLES TOWN, W.Va., April 2, 2008 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. , developers of state of the art electronic devices for diabetic peripheral neuropathy, Molluscum Contagiosum, and MRSA; today reported March sales numbers exceeding all previous months.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
“Our March sales topped $410,000; continuing the company’s growth curve. We expect to continue that growth during the rest of this year,” says David B. Phillips, Ph.D., President of ReBuilder Medical Technology, Inc. (RBRM) “Many investors have begun to appreciate that even in this recession, we are a sound company, with no debt to service, manufacturing our own medical products with American parts and American labor, and with a large overseas market. We have been operating in the same facility with the same management since 2003.”
For more information visit: http://www.rebuildermedical.com and http://www.molluscum.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words “estimate,” “anticipate,” “expect,” “believe,” and similar expressions are intended to be forward-looking statements.
Contact: Daena Carter of ReBuilder Medical Technologies, Inc.
+1-304-725-2202
CONTACT: Daena Carter of ReBuilder Medical Technologies, Inc.,
+1-304-725-2202
Web site: http://www.molluscum.com/
http://www.rebuildermedical.com/
